Monaco Asset Management’s Mereo BioPharma MREO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,585,214
Closed -$661K 90
2025
Q4
$661K Buy
1,585,214
+639,299
+68% +$1.22M 0.11% 70
2025
Q3
$1.95M Buy
945,915
+550,915
+139% +$1.02M 0.12% 53
2025
Q2
$1.07M Sell
395,000
-21,468
-5% -$51.8K 0.19% 63
2025
Q1
$937K Buy
416,468
+35,000
+9% +$99K 0.19% 52
2024
Q4
$1.34M Sell
381,468
-3,067
-0.8% -$12.1K 0.19% 53
2024
Q3
$1.58M Buy
384,535
+36,407
+10% +$151K 0.23% 47
2024
Q2
$1.25M Sell
348,128
-56,872
-14% -$184K 0.2% 39
2024
Q1
$1.34M Sell
405,000
-271,494
-40% -$919K 0.4% 40
2023
Q4
$1.56M Buy
676,494
+80,765
+14% +$154K 0.46% 47
2023
Q3
$768K Sell
595,729
-110,000
-16% -$146K 0.23% 55
2023
Q2
$932K Sell
705,729
-610,516
-46% -$708K 0.26% 51
2023
Q1
$930K Sell
1,316,245
-733,416
-36% -$660K 0.29% 49
2022
Q4
$1.54M Buy
2,049,661
+1,863,005
+998% +$1.53M 0.46% 45
2022
Q3
$161K Buy
+186,656
New +$228K 0.06% 66

Other funds holding MREO